Federal Register / Vol. 72, No. 72 / Monday, April 16, 2007 / Notices 19003 

1600 Clifton Road, Mail Stop E–28, 

Atlanta, GA 30303, telephone: 404/498–

0003, fax: 404/498–0059, E-mail: 

smalcom@cdc.gov. The deadline for 

notification of attendance is May 2, 

2007. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities for both CDC and 

the Agency for Toxic Substances and 

Disease Registry. 

Dated: April 9, 2007. 

Elaine L. Baker, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–7188 Filed 4–13–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare and Medicaid 

Services 

Delegation of Authority 

Notice is hereby given that I have 

delegated to the Administrator of the 

Centers for Medicare and Medicaid 

Services, the following authority vested 

in the Secretary of Health and Human 

Services. 

Subpoenas for the Health Insurance 

Portability and Accountability Act of 

1996 (HIPAA): Authority under Section 

205(d) of the Social Security Act (42 

U.S.C. 405(d)), with authority to 

redelegate, to issue subpoenas requiring 

the attendance and testimony of 

witnesses and the production of any 

evidence that relates to any matter 

under investigation or compliance 

review for failure to comply with the 

Health Insurance Portability and 

Accountability Act of 1996 (HIPAA) 

standards and requirements related at 

45 CFR parts 160, 162 and 164 (except 

to the extent they pertain to the 

standards for privacy of individually 

identifiable health information). 

Section 1176(a)(2) of the Social 

Security Act, 42 U.S.C. 1320d–5(a)(2), 

which provides authority for the 

imposition of civil money penalties 

(CMPs) for violations, makes section 

1128A of the Social Security Act, 42 

U.S.C. 1320a–7a, applicable to the 

imposition of CMPs for violations of 

HIPAA administrative simplification 

standards. Section 1128A(j)(1), 42 

U.S.C. 1320a–7a(j)(l), makes section 

205(d) and (e) of the Social Security Act, 

42 U.S.C. 405(d) and (e), applicable to 

section 1128A as the subsections are 

with respect to Title II of the Social 

Security Act. Section 205(d) and (e) 

authorizes the issuance of subpoenas 

requiring the attendance and testimony 

of witnesses and the production of any 

evidence that relates to any matter 

under investigation by the Secretary and 

the enforcement of such a subpoena in 

court in event of refusal to comply. 

This delegation shall be exercised 

under the Department’s existing 

delegation of authority on the issuance 

of regulations and existing policy on the 

issuance of regulations. 

In addition, I hereby affirm and ratify 

any actions taken by the Administrator 

of the Centers for Medicare and 

Medicaid Services, or his subordinates 

which involved the exercise of the 

authority delegated herein prior to the 

effective date of this delegation. 

This delegation is effective 

immediately. 

Michael O. Leavitt, 

Secretary. 

[FR Doc. 07–1871 Filed 4–13–07; 8:45 am] 

BILLING CODE 4120–03–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

Vaccines and Related Biological 

Products Advisory Committee; Notice 

of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). At least one portion of the 

meeting will be closed to the public. 

Name of Committee: Vaccines and 

Related Biological Products Advisory 

Committee. 

General Function of the Committee: 

To provide advice and 

recommendations to the agency on 

FDA’s regulatory issues. 

Date and Time: The meeting will be 

held on May 16, 2007, from 9 a.m. to 

4:30 p.m. and on May 17, 2007, from 8 

a.m. to 1 p.m. 

Location: Hilton Hotel, Washington 

DC North/Gaithersburg, 620 Perry 

Pkwy., Gaithersburg, MD 20877. 

Contact Person: Christine Walsh or 

Denise Royster, Center for Biologics 

Evaluation and Research (HFM–71), 

Food and Drug Administration, 1401 

Rockville Pike, Rockville, MD 20852, 

301–827–0314, or FDA Advisory 

Committee Information Line, 1–800–

741–8138 (301–443–0572 in the 

Washington, DC area), code 

3014512391. Please call the Information 

Line for up-to-date information on this 

meeting. 

Agenda: On May 16, 2007, in the 

morning session, the committee will 

hear presentations and make 

recommendations on the safety and 

effectiveness of influenza virus vaccine 

live (FluMist) in a pediatric population 

less than 59 months of age, 

manufactured by MedImmune Vaccines, 

Inc. In the afternoon, the committee will 

hear an overview of the function of the 

Laboratory of Bacterial Polysaccharides 

and the Laboratory of Enteric & Sexually 

Transmitted Diseases, Division of 

Bacterial Parasitic and Allergenic 

Products, Office of Vaccines Research 

and Review, CBER and in closed session 

will discuss the report of the November 

29, 2006, laboratory site visit. On May 

17, 2007, the committee will hear 

presentations and make 

recommendations on the safety and 

immunogenicity of a live vaccinia virus 

smallpox vaccine (ACAM2000) 

manufactured by Acambis, Inc. 

FDA intends to make background 

material available to the public no later 

than 1 business day before the meeting. 

If FDA is unable to post the background 

material on its Web site prior to the 

meeting, the background material will 

be made publicly available at the 

location of the advisory committee 

meeting, and the background material 

will be posted on FDA’s Web site after 

the meeting. Background material is 

available at http://www.fda.gov/ohrms/ 

dockets/ac/acmenu.htm, click on the 

year 2007 and scroll down to the 

appropriate advisory committee link. 

Procedure: On May 16, 2007, from 9 

a.m. to 3:50 p.m. and on May 17, 2007, 

from 8 a.m. to 1 p.m., the meeting is 

open to the public. Interested persons 

may present data, information, or views, 

orally or in writing, on issues pending 

before the committee. Written 

submissions may be made to the contact 

person on or before May 2, 2007. Oral 

presentations from the public will be 

scheduled between approximately 11:45 

a.m. to 12:15 p.m. and 3:20 p.m. to 3:50 

p.m. on May 16, 2007, and between 

approximately 11:15 a.m. to 11:45 a.m. 

on May 17, 2007. Those desiring to 

make formal oral presentations should 

notify the contact person and submit a 

brief statement of the general nature of 

the evidence or arguments they wish to 

present, the names and addresses of 

proposed participants, and an 

indication of the approximate time 

requested to make their presentation on 

or before April 24, 2007. Time allotted 

for each presentation may be limited. If 

the number of registrants requesting to 


cprice-sewell on PROD1PC66 with NOTICES